# Revelation Biosciences, Inc.: Form 8-K, filed Oct 21, 2024

- Company: [Revelation Biosciences, Inc.](/companies/revb.md) (CIK 1810560)
- Form: 8-K
- Filed: 2024-10-21
- Accepted by EDGAR: Oct 21, 2024, 16:19 ET
- Period: 2024-10-16
- Accession: 0000950170-24-115955
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1810560/000095017024115955/revb-20241016.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1810560/000095017024115955/

## Items reported

- Item 3.01: Delisting notice
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1810560/000095017024115955/revb-20241016.htm

Filed Oct 21, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-115955. Last ingested by Listed: Nov 5, 2026, 21:10 ET. No prices; not investment advice.